Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Adapt Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Adapt Pharma Enters into Co-Development Agreement with Profector Life Sciences 11
Licensing Agreements 12
Lightlake Therapeutics Enters into Licensing Agreement with Adapt Pharma Operations 12
Equity Offering 13
Adapt Pharma Raises USD95 Million in Private Placement of Shares 13
Acquisition 14
Emergent BioSolutions Acquires Adapt Pharma for USD735 Million 14
Adapt Pharma Ltd – Key Competitors 16
Adapt Pharma Ltd – Key Employees 17
Adapt Pharma Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Product News 19
12/20/2017: Opiant Pharmaceuticals Announces Significant Financial Developments Related to NARCAN Nasal Spray for Opioid Overdose 19
11/03/2017: Adapt Pharma Presents Human Factors Study Data on Usability of NARCAN (naloxone HCl) Nasal Spray at the 41st Association for Medical Education & Research in Substance Abuse Annual National Conference 20
10/24/2018: Emergent BioSolutions to offer all public libraries and YMCAs in the U.S. free opioid awareness education and NARCAN (naloxone HCl) Nasal Spray 21
10/24/2017: Walgreens Stocking Life Saving Narcan Nasal Spray in All Pharmacies Nationwide 22
10/17/2017: Adapt Pharma Launches Roll Call Training Video to Educate Law Enforcement on NARCAN (naloxone HCl) Nasal Spray 4mg 23
09/15/2017: Opiant Pharmaceuticals Provides an Update on NARCAN Nasal Spray 24
08/10/2017: Opiant Pharmaceuticals Announces Additional $3.75 Million Payment From NARCAN Nasal Spray Royalty Monetization 25
07/12/2018: Aetna Donates Narcan to Wayne County 26
06/26/2018: Albertsons Companies Offers Increased Access to Naloxone 27
06/06/2017: Survey Data Published on Community Use of NARCAN (naloxone HCI) Nasal Spray 4 mg to Help Reverse Opioid-Related Overdose – Current Medical Research and Opinion Journal 28
05/29/2018: ADAPT Pharma Launches New Online Platform for NARCAN 29
05/09/2018: Quebec Government makes NARCAN Nasal Spray free to anyone 14 years or older through Free naloxone program 30
04/30/2018: A Retrospective Analysis & Literature Review Published in Pain Management on the Pharmacokinetic Properties of Naloxone Approved for Community Use Highlights Bioequivalence of Dose & Usability 31
04/26/2018: Adapt Pharma donates 20,000 doses of NARCAN (naloxone HCl) Nasal Spray to the National Council for Behavioral Health and its Residential Treatment Member Organizations 32
04/25/2018: A Retrospective Literature Review Published in Pain Management on Prescribing Naloxone for Opioid Overdose Intervention Highlights Opportunities to Expand Community Access to Help Reduce Fatalities 33
04/24/2017: Emergency opioid treatment NARCAN Nasal Spray added to NIHB Program in Canada 34
04/11/2017: Ontario ministries make NARCAN Nasal Spray available to general public 35
04/10/2017: Adapt Pharma Expands Free NARCAN Nasal Spray Program to U.S. Colleges and Universities 36
04/09/2018: Adapt Pharma Welcomes Canadian & Ontario Governments Programs Providing NARCAN (naloxone HCl) Nasal Spray Free of Charge to NIHB Clients and All Ontarians through Pharmacies 37
04/05/2018: ADAPT Pharma Welcomes Surgeon General Naloxone Advisory 39
04/05/2018: CVS Health Expands Efforts to Educate Patients about Naloxone 40
04/04/2018: Cardinal Health Begins Donation of Over 80,000 Doses of Life-Saving Narcan for Distribution to Law Enforcement and First Responders in Appalachia 41
03/27/2017: Opiant Pharmaceuticals Announces Results of Positron Emission Tomography Study of Naloxone Nasal Spray 42
03/19/2018: ADAPT Pharma Expands Program Offering Free NARCAN (naloxone HCl) Nasal Spray to Eligible Schools and Universities 43
03/16/2017: New Data Presented on Adapt Pharmas Community Use of Narcan Nasal Spray 4 mg to Reverse Opioid-Related Overdose 44
03/05/2018: Adapt Pharma Expands Technical and R&D Teams 45
02/28/2017: Adapt Pharma Marks One-Year Anniversary of NARCAN Nasal Spray (naloxone HCl) 4mg Launch in the U.S. 46
02/13/2018: Aptar and Adapt Pharma Donate 5,000 Doses of NARCAN to Opioid Crisis Coalitions in Illinois 47
02/08/2018: Opiant Pharmaceuticals to Record Approximately $11.7 Million in Royalty and Milestone Payments Related to 2017 Sales of NARCAN Nasal Spray for Opioid Overdose 48
01/31/2018: Aegis Selects NARCAN (naloxone HCl) Nasal Spray to Help Combat Opioid Epidemic, Increasing Access to Life-saving Treatment in LA County 49
01/30/2017: Kroger Pharmacies to Increase Access to Naloxone in North Texas, East Texas and Southeast Texas 50
01/26/2017: Opiant Pharmaceuticals Announces FDA Approval of 2mg Formulation of NARCAN (naloxone HCI) Nasal Spray 51
01/09/2017: Opiant Pharmaceuticals Featured in Recent Media Highlighting NARCAN Nasal Spray and Heroin Vaccine Development 52
Product Approvals 53
Aug 04, 2017: Opiant Pharmaceuticals Announces FDA Orange Book Listing for New NARCAN Nasal Spray Patent 53
Jun 27, 2017: Opiant Pharmaceuticals Announces FDA Orange Book Listing for New NARCAN Nasal Spray Patent 54
Mar 09, 2017: Opiant Pharmaceuticals Announces FDA Orange Book Listings for Two New NARCAN Nasal Spray Patents 55
Feb 21, 2017: Adapt Pharma Announces European Marketing Application Filed For Naloxone Hydrochloride Nasal Spray 56
Jan 25, 2017: NARCAN (naloxone HCl) Nasal Spray 2mg Approved by US Food and Drug Administration 57
Clinical Trials 58
Jan 11, 2017: Opiant Pharmaceuticals Announces 2017 Corporate and Clinical Goals 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Adapt Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Adapt Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adapt Pharma Enters into Co-Development Agreement with Profector Life Sciences 11
Lightlake Therapeutics Enters into Licensing Agreement with Adapt Pharma Operations 12
Adapt Pharma Raises USD95 Million in Private Placement of Shares 13
Emergent BioSolutions Acquires Adapt Pharma for USD735 Million 14
Adapt Pharma Ltd, Key Competitors 16
Adapt Pharma Ltd, Key Employees 17
Adapt Pharma Ltd, Subsidiaries 18
List of Figures
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Adapt Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9